NDC 17856-0060-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0060
- Requested NDC
- 17856-0060-01
- Package NDCs from labels
- 17856-0060-1, 17856-0060-3, 17856-0060-2, 17856-0060-4, 17856-0060-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEGESTROL ACETATE ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0060-1 | Megestrol Acetate | 10 mL in 1 CUP | SUSPENSION | 10 | 3 | |
| 17856-0060-2 | Megestrol Acetate | 20 mL in 1 CUP | SUSPENSION | 20 | 3 | |
| 17856-0060-3 | Megestrol Acetate | 72 in 1 BOX | SUSPENSION | 72 | 3 | |
| 17856-0060-4 | Megestrol Acetate | 50 in 1 BOX | SUSPENSION | 50 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0060 | MEGESTROL ACETATE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250524_01119031-9943-4afb-8b45-cb71682f0482.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOCUSATE SODIUM | DOCUSATE SODIUM | A-S Medication Solutions | 946abcdb-96bd-43e6-992a-bb97679c00f0 | 2024-12-30 | Warnings | F05Q2T2JA0 |
| Gut Brain Spectrum | ABROTANUM (ARTEMISIA ABROTANUM), AETHUSA CYNAPIUM, BAPTISIA TINCTORIA, CICUTA VIROSA, CUPRUM METALLICUM, MEZEREUM, BUFO RANA, LAC MATERNA HUMANUM, SACCHARUM OFFICINALE, SEROTONIN (HYDROCHLORIDE), ALUMINA, CALCAREA PHOSPHORICA, CANDIDA ALBICANS, CARCINOSIN, LAC CANINUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PROPIONIC ACID, SULPHUR, THUJA OCCIDENTALIS, FORMALINUM, MORBILLINUM | Energique, Inc. | adfee6ce-05b0-4955-bf5f-9612b8db4c78 | 2024-12-26 | Warnings | C151H8M554 |
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| GeriCare Docusate Sodium Liquid | DOCUSATE SODIUM | GERI-CARE PHARMACEUTICALS, CORP | e50558e1-f0c8-4b03-9109-6a273b61730d | 2024-12-20 | Warnings | F05Q2T2JA0 |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | RUGBY LABORATORIES | f5afd8eb-d35d-44ab-897d-1d41c98ca138 | 2024-12-19 | Warnings | F05Q2T2JA0 |
| Senexon-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | RUGBY LABORATORIES | 2e758ff1-3083-4245-8f58-1c47b042bfdd | 2024-12-19 | Warnings | F05Q2T2JA0 |
| Quality Choice Stool Softener | DOCUSATE SODIUM | Chain Drug Marketing Association | 4d5facd4-f57f-44f7-b8dd-83a33e57afd9 | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Good Neighbor Stool Softener | DOCUSATE SODIUM | AmerisourceBergen Drug Corp | 88d657a1-77be-412a-9295-034872db2dde | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Preferred Stool Softener | DOCUSATE SODIUM | Reese Pharmaceutical Co | 217d13a0-3205-492c-af49-82eb80dba53a | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Topcare Stool Softener | DOCUSATE SODIUM | TOPCO ASSOCIATES LLC | 9342c1b5-5d35-4b60-b347-c208c0774cdc | 2024-12-18 | Warnings | F05Q2T2JA0 |
| HEB Stool Softener | DOCUSATE SODIUM | H E B | 3a513cb9-8404-43dc-a780-040bf9f1741d | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Topcare Stool Softener laxative | DOCUSATE SODIUM | TOPCO ASSOCIATES LLC | f9302fc2-684d-4cc2-bdd7-7ad0e9304edb | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Good Neighbor Stool Softener laxative | DOCUSATE SODIUM | AmerisourceBergen Drug Corp | d09151ae-1cc6-4e69-8d80-7813082a4236 | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Winco Stool Softener | DOCUSATE SODIUM | WinCo Foods, LLC | 4de2e315-5ec6-4ddf-8617-4e07ba456354 | 2024-12-18 | Warnings | F05Q2T2JA0 |
| H E B Stool Softener laxative | DOCUSATE SODIUM | H E B | 9d848fdd-3a2f-45c6-9ff3-17f1d74e0f4f | 2024-12-18 | Warnings | F05Q2T2JA0 |
| Preferred Stool Softener laxative | DOCUSATE SODIUM | Reese Pharmaceutical Co | 9135addd-4fc7-411b-b3c3-79e7e0e4cec8 | 2024-12-18 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.